Literature DB >> 19143738

Automatic extraction of ECG strips from continuous 12-lead holter recordings for QT analysis at prescheduled versus optimized time points.

Fabio Badilini1, Martino Vaglio, Nenad Sarapa.   

Abstract

BACKGROUND: Continuous 12-lead ECG monitoring (Holter) in early-phase pharmaceutical studies is today widely used as an ideal platform to extract discrete ECGs for analysis. The extraction process is typically performed manually by trained readers using commercial Holter processing systems.
METHODS: Antares, a novel method for automatic 12-lead extraction from continuous Holter recordings applying minimal noise criteria and heart-rate stability conditions is presented. A set of 12-lead Holter recordings from healthy subjects administered with sotalol is used to compare ECG extractions at fixed time points with ECG extractions generated by Antares optimizing noise and heart rate inside 5 minute windows centered around each expected time point of interest.
RESULTS: Global, low- and high-frequency noise content of extracted ECGs was significantly reduced via optimized approach by Antares. Heart rate was also slightly reduced (from 69 +/- 13 to 64 +/- 13 bpm, P < 0.05). Similarly, the corrected QT interval from optimized extractions was significantly reduced (QTcB from 414 +/- 32 to 402 +/- 30 ms, P < 0.05). Using only baseline data, and after adjusting for intersubject variability, the standard deviation (SD) of QT intervals was highly reduced with optimized extraction (SD of QTcF from 11 +/- 8 to 7 +/- 2 ms, P < 0.05).
CONCLUSIONS: Extraction of discrete 12-lead ECG strips from continuous Holter generates less noisy and more stable ECGs leading to more robust QTc data, thereby potentially facilitating the assessment of ECG effects on clinical trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19143738      PMCID: PMC6932623          DOI: 10.1111/j.1542-474X.2008.00260.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  9 in total

1.  QT interval analysis on ambulatory electrocardiogram recordings: a selective beat averaging approach.

Authors:  F Badilini; P Maison-Blanche; R Childers; P Coumel
Journal:  Med Biol Eng Comput       Date:  1999-01       Impact factor: 2.602

2.  Identification of sotalol-induced changes in repolarization with T wave area-based repolarization duration parameters.

Authors:  Jean-Philippe Couderc; Wojciech Zareba; Arthur J Moss; Nenad Sarapa; Joel Morganroth; Borje Darpo
Journal:  J Electrocardiol       Date:  2003       Impact factor: 1.438

3.  The ISCE ECG genome pilot challenge: a 2004 progress report.

Authors:  Paul Kligfield; Fabio Badilini; Barry Brown; Erich Helfenbein; Mark Kohls
Journal:  J Electrocardiol       Date:  2004       Impact factor: 1.438

4.  Digital 12-lead Holter in the assessment of drug effects on cardiac repolarization.

Authors:  Nenad Sarapa
Journal:  J Electrocardiol       Date:  2005-07       Impact factor: 1.438

5.  Contrasting time- and rate-based approaches for the assessment of drug-induced QT changes.

Authors:  Fabrice Extramiana; Fabio Badilini; Nenad Sarapa; Antoine Leenhardt; Pierre Maison-Blanche
Journal:  J Clin Pharmacol       Date:  2007-07-26       Impact factor: 3.126

6.  Control of rapid heart rate changes for electrocardiographic analysis: implications for thorough QT studies.

Authors:  Fabrice Extramiana; Pierre Maison-Blanche; Abdeddayem Haggui; Fabio Badilini; Philippe Beaufils; Antoine Leenhardt
Journal:  Clin Cardiol       Date:  2006-12       Impact factor: 2.882

7.  Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.

Authors:  Nenad Sarapa; Joel Morganroth; Jean-Philippe Couderc; Steven F Francom; Borje Darpo; Joseph C Fleishaker; Janet D McEnroe; William T Chen; Wojciech Zareba; Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

8.  Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies.

Authors:  M R Franz; C D Swerdlow; L B Liem; J Schaefer
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

9.  Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction.

Authors:  Esther Pueyo; Peter Smetana; Pere Caminal; Antonio Bayes de Luna; Marek Malik; Pablo Laguna
Journal:  IEEE Trans Biomed Eng       Date:  2004-09       Impact factor: 4.538

  9 in total
  9 in total

1.  Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.

Authors:  David G Strauss; Jose Vicente; Lars Johannesen; Ksenia Blinova; Jay W Mason; Peter Weeke; Elijah R Behr; Dan M Roden; Ray Woosley; Gulum Kosova; Michael A Rosenberg; Christopher Newton-Cheh
Journal:  Circulation       Date:  2017-02-17       Impact factor: 29.690

2.  Automated versus manual measurement of the QT interval and corrected QT interval.

Authors:  Yuji Kasamaki; Yukio Ozawa; Masakatsu Ohta; Akira Sezai; Takashi Yamaki; Mutsuo Kaneko; Ichiro Watanabe; Atsushi Hirayama; Tomohiro Nakayama
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

3.  Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial.

Authors:  L Johannesen; J Vicente; J W Mason; C Erato; C Sanabria; K Waite-Labott; M Hong; J Lin; P Guo; A Mutlib; J Wang; W J Crumb; K Blinova; D Chan; J Stohlman; J Florian; M Ugander; N Stockbridge; D G Strauss
Journal:  Clin Pharmacol Ther       Date:  2015-11-28       Impact factor: 6.875

4.  Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.

Authors:  Borje Darpo; Dilip R Karnad; Fabio Badilini; Jeff Florian; Christine E Garnett; Snehal Kothari; Gopi Krishna Panicker; Nenad Sarapa
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

5.  Electrocardiographic data quality in thorough QT/QTc studies.

Authors:  Lars Johannesen; Christine Garnett; Marek Malik
Journal:  Drug Saf       Date:  2014-03       Impact factor: 5.606

6.  Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil.

Authors:  Jose Vicente; Lars Johannesen; Jay W Mason; William J Crumb; Esther Pueyo; Norman Stockbridge; David G Strauss
Journal:  J Am Heart Assoc       Date:  2015-04-13       Impact factor: 5.501

7.  Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk.

Authors:  Lars Johannesen; Jose Vicente; Meisam Hosseini; David G Strauss
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

8.  Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study.

Authors:  Jose Vicente; Robbert Zusterzeel; Lars Johannesen; Roberto Ochoa-Jimenez; Jay W Mason; Carlos Sanabria; Sarah Kemp; Philip T Sager; Vikram Patel; Murali K Matta; Jiang Liu; Jeffry Florian; Christine Garnett; Norman Stockbridge; David G Strauss
Journal:  Clin Pharmacol Ther       Date:  2019-01-18       Impact factor: 6.875

9.  Comparing the consistency of electrocardiogram interval measurements by resting ECG versus 12-lead Holter.

Authors:  Boaz Mendzelevski; Christopher S Spencer; Anne Freier; Dorothée Camilleri; Claus Graff; Jörg Täubel
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-05-04       Impact factor: 1.468

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.